Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Affimed N.V. (AFMD)

Affimed N.V. (AFMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Affimed N.V.: Q3 Earnings Snapshot

Affimed N.V.: Q3 Earnings Snapshot

AFMD : 4.88 (unch)
Affimed N.V.: Q2 Earnings Snapshot

Affimed N.V.: Q2 Earnings Snapshot

AFMD : 4.88 (unch)
Affimed N.V.: Q1 Earnings Snapshot

Affimed N.V.: Q1 Earnings Snapshot

AFMD : 4.88 (unch)
Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates

Clearside Biomedical, Inc. (CLSD) delivered earnings and revenue surprises of -7.14% and 98.44%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

CLSD : 1.2600 (-5.97%)
AFMD : 4.88 (unch)
Exelixis (EXEL) Lags Q1 Earnings and Revenue Estimates

Exelixis (EXEL) delivered earnings and revenue surprises of -30.43% and 4.47%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

EXEL : 23.53 (-0.76%)
AFMD : 4.88 (unch)
Affimed N.V. (AFMD) Reports Q4 Loss, Tops Revenue Estimates

Affimed N.V. (AFMD) delivered earnings and revenue surprises of -15.79% and 45.75%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

AFMD : 4.88 (unch)
NRIX : 12.36 (-10.11%)
Liquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Tops Revenue Estimates

Liquidia Technologies, Inc. (LQDA) delivered earnings and revenue surprises of 47.06% and 46.73%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the...

LQDA : 12.37 (-1.43%)
AFMD : 4.88 (unch)
Ikena Oncology, Inc. (IKNA) Reports Q4 Loss, Tops Revenue Estimates

Ikena Oncology, Inc. (IKNA) delivered earnings and revenue surprises of 26.42% and 67.02%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

IKNA : 1.3100 (+1.55%)
AFMD : 4.88 (unch)
Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates

Anika (ANIK) delivered earnings and revenue surprises of -54.55% and 3.41%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ANIK : 25.58 (-1.24%)
AFMD : 4.88 (unch)
NGM Biopharmaceuticals (NGM) Reports Q4 Loss, Tops Revenue Estimates

NGM Biopharmaceuticals (NGM) delivered earnings and revenue surprises of 13.46% and 166.31%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?...

NGM : 1.5400 (-1.28%)
AFMD : 4.88 (unch)

Barchart Exclusives

This Dividend King Is Now One of BofA's Investment Best Ideas
Discover why S&P Global, a seasoned Dividend King, has not only secured a spot on Bank of America's prestigious US 1 List, but also why analysts are bullish about its investment potential in the current economic climate. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar